Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

Sara Thønnings,1,2 Filip Jansåker,1,3 Kim Oren Gradel,4,5 Bjarne Styrishave,2 Jenny Dahl Knudsen11Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Denmark; 2Toxicology Laboratory, Analytical BioSciences, Department of Pharmacy, University of Copenha...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Infection and Drug Resistance
المؤلفون الرئيسيون: Thønnings S, Jansåker F, Gradel KO, Styrishave B, Knudsen JD
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Dove Medical Press 2019-05-01
الموضوعات:
Piperacillin/tazobactam
Cefuroxime
E. coli
Bacteremia
Mortality
الوصول للمادة أونلاين:https://www.dovepress.com/cefuroxime-compared-to-piperacillintazobactam-as-empirical-treatment-o-peer-reviewed-article-IDR

الانترنت

https://www.dovepress.com/cefuroxime-compared-to-piperacillintazobactam-as-empirical-treatment-o-peer-reviewed-article-IDR

مواد مشابهة